BiotechTube
Home/HOOKIPA Pharma/Mark Winderlich
MW

Mark Winderlich

Chief Research & Development Officer

HOOKIPA Pharma

Therapeutic Areas

OncologyInfectious Diseases

HOOKIPA Pharma Pipeline

DrugIndicationPhase
HB-200 (Eseba-vec)HPV16+ recurrent/metastatic Head and Neck CancerPhase 2
HB-300KRAS-mutated advanced solid tumorsPhase 1/2
HB-500HIV (Therapeutic)Preclinical
HB-700Cytomegalovirus (CMV) Prophylactic VaccinePreclinical
Gilead Partnership ProgramHIV (Therapeutic)Phase 1

Leadership Team at HOOKIPA Pharma

MP
Malte Peters
Chief Executive Officer
TC
Terry Coelho
Executive Vice President & Chief Financial Officer
RZ
Rolf Zinkernagel
Co-Founder
AB
Andreas Bergthaler
Co-Founder
LF
Lukas Flatz
Co-Founder
DP
Daniel Pinschewer
Co-Founder
View full HOOKIPA Pharma profile